EGFR and neoplasm: EGFR expression levels vary over orders of magnitude between cell types (Herbst, 2004) and are commonly elevated in tumor cells (Sanchez-Vega et al., 2018), so it is important to know whether simply altering EGFR expression is sufficient to override stiffness-related modulation.